Study of Intravenous RXDX-107 in Patients With Solid Tumors

NCT02548390 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
70
Enrollment
INDUSTRY
Sponsor class

Stopped Company decision

Conditions

Interventions

Sponsor

Hoffmann-La Roche